Skip to main content
. 2019 Apr-Jun;11(2):98–101. doi: 10.32607/20758251-2019-11-2-98-101

Fig. 2.

Fig. 2

MDA-MB-231 tumor in xenograft mice before (A) and after (B) treatment with a iRGD-MS2-Tl+ preparation